253840 — Sugentech Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Sugentech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	41,352	77,201	101,399	7,132	10,097
Cost of Revenue
Gross Profit	31,493	48,145	43,861	-4,155	-1,207
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	11,770	42,386	76,428	31,152	35,490
Operating Profit	29,582	34,816	24,971	-24,020	-25,393
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-40,817	43,310	32,322	-18,722	-20,785
Provision for Income Taxes
Net Income After Taxes	-41,069	36,150	26,678	-17,378	-15,370
Minority Interest
Net Income Before Extraordinary Items
Net Income	-41,018	36,152	26,717	-17,238	-15,193
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-41,018	36,152	26,717	-17,238	-15,193
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3,263	2,160	1,481	-1,034	-851
Dividends per Share